In conclusion, we identified corifungin as amebicidal and cysticidal for A. castellanii. Considering its earlier efficacy against another free-living ameba, N. fowleri, and its orphan-drug designation in the treatment of primary amebic meningoencephalitis, corifungin now represents a promising therapeutic option for Acanthamoeba infection.